HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas Adejumo Selected Research

ICL-CCIC-0019

6/2016The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas Adejumo Research Topics

Disease

3Neoplasms (Cancer)
01/2018 - 06/2016

Drug/Important Bio-Agent (IBA)

1LigandsIBA
01/2018
1Phosphatidylcholines (Phosphatidylcholine)IBA
06/2016
1Phospholipids (Phosphatides)FDA LinkGeneric
06/2016
1Phosphorylcholine (Phosphocholine)IBA
06/2016
1ICL-CCIC-0019IBA
06/2016
1Glycerophospholipids (Phosphoglycerides)IBA
06/2016
1Choline (Choline Chloride)IBA
06/2016
1Choline KinaseIBA
06/2016

Therapy/Procedure

1Therapeutics
01/2018